Attila J Szabó

13PUBLICATIONS
79CO-AUTHORS
Medical devicesNeurology and neuromuscular diseasesInfant and child healthNutritional epidemiologyOptical technology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Mar 28, 2026
The Sigma-1 Receptor Agonist Fluvoxamine Is Protective in Hyperglycaemia-Induced Dysfunction of Trabecular Meshwork Cells.

Alexandra Rozsahegyi, Marcell Cserhalmi, Timea Medveczki

|Dec 01, 2025
A Nonparametric Population Pharmacokinetic Model of Selumetinib in Pediatric Patients Diagnosed With Neurofibromatosis-I or Plexiform Neurofibromas.

Zoltán Köllő, Janka Kovács, Michael N Neely

|Jun 27, 2024
Perinatal asphyxia leads to acute kidney damage and increased renal susceptibility in adulthood.

Tamas Lakat, Andrea Fekete, Kornel Demeter

|Dec 18, 2023
Higher parental education was associated with good cognitive outcomes in infants with hypoxic-ischaemic encephalopathy.

Zsuzsanna Varga, Csilla Andorka, Margit Pataki

|Jul 29, 2023
Sigma-1 Receptor Agonist Fluvoxamine Ameliorates Fibrotic Response of Trabecular Meshwork Cells.

Judit Hodrea, Minh Ngoc Tran, Balazs Besztercei

Pageof 3